Your browser doesn't support javascript.
loading
The prevalence of probable neuropathic pain in the US: results from a multimodal general-population health survey.
DiBonaventura, Marco D; Sadosky, Alesia; Concialdi, Kristen; Hopps, Markay; Kudel, Ian; Parsons, Bruce; Cappelleri, Joseph C; Hlavacek, Patrick; Alexander, Andrea H; Stacey, Brett R; Markman, John D; Farrar, John T.
Afiliação
  • DiBonaventura MD; Health Outcomes Practice, Kantar Health.
  • Sadosky A; Pfizer Inc, New York, NY.
  • Concialdi K; Health Outcomes Practice, Kantar Health.
  • Hopps M; Pfizer Inc, New York, NY.
  • Kudel I; Health Outcomes Practice, Kantar Health.
  • Parsons B; Pfizer Inc, New York, NY.
  • Cappelleri JC; Pfizer Inc, Groton, CT.
  • Hlavacek P; Pfizer Inc, New York, NY.
  • Alexander AH; Pfizer Inc, New York, NY.
  • Stacey BR; University of Washington, Seattle, WA.
  • Markman JD; University of Rochester School of Medicine and Dentistry, Rochester, NY.
  • Farrar JT; University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, US.
J Pain Res ; 10: 2525-2538, 2017.
Article em En | MEDLINE | ID: mdl-29138590
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prevalence_studies / Risk_factors_studies Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prevalence_studies / Risk_factors_studies Idioma: En Ano de publicação: 2017 Tipo de documento: Article